Innovotech

Innovotech EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Innovotech (IOT.V) as of Nov 20, 2026 is 121,624.00 CAD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 89,409.00 CAD — a change of 36.03% (higher).

EBITDA

121,624.00CAD

YoY

36.03%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Innovotech is 2025 121,624.00 CAD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Innovotech was 2024 89,409.00 CAD. It decreases by 36.03% higher compared to the previous year.

The Innovotech EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-126,987.00 CAD
Jan 1, 2019
-40,261.00 CAD
Jan 1, 2020
99,317.00 CAD
Jan 1, 2021
267,952.00 CAD
Jan 1, 2022
-140,449.00 CAD
Jan 1, 2023
-373,371.00 CAD
Jan 1, 2024
89,409.00 CAD
Jan 1, 2025
121,624.00 CAD
The Innovotech EBITDA history
YEAREBITDAYoY
121,624.00CAD+36.03%
89,409.00CAD-123.95%
-373,371.00CAD+165.84%
-140,449.00CAD-152.42%
267,952.00CAD+169.79%
99,317.00CAD-346.68%
-40,261.00CAD-68.30%
-126,987.00CAD-452.54%
36,021.00CAD-58.15%
86,063.00CAD-150.05%
-171,970.00CAD+22.32%
-140,586.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Innovotech Stock analysis

What does Innovotech do? Innovotech Inc. generates revenue through the sale of proprietary assay kits, including MBEC Assay Kits, Order Biofilm Assays, and Coated MBEC Assay Lids, which are used in microbial biofilm research. The company also provides contract research services such as Antimicrobial Contract Research, Antimicrobial and Anti-Biofilm Agents testing (MIC and MBEC), and Customized Antimicrobial Testing (BEST Assay Testing and Implanted Medical Device Testing). Its antimicrobial silver products, AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products, are sold to customers in agricultural and medical sectors. The firm targets research institutions, agricultural producers, and medical device manufacturers seeking biofilm and antimicrobial testing solutions. Innovotech's intellectual property portfolio supports its contract research services, which include testing for antimicrobial agents and materials under standards like TM100, ISO 22196, and USP 51. The company’s Biofilm Publications and SEM Library serve as additional resources for clients engaged in biofilm research. Its product offerings are tailored to sectors requiring microbial biofilm analysis, such as crop protection and medical device development, with AgreGuard-1 and InnovoSIL products specifically addressing antimicrobial needs in agriculture and medical applications. The company monetizes its proprietary technology through direct sales of assay kits and antimicrobial silver products, while contract research services provide recurring revenue streams. Clients include research organizations conducting biofilm studies, agricultural businesses using AgreGuard-1 for crop protection, and medical device manufacturers utilizing InnovoSIL for antimicrobial properties. Innovotech’s focus on specialized testing methodologies and branded products ensures consistent demand from niche markets requiring precise biofilm and antimicrobial evaluation. Innovotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Innovotech stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Innovotech is 121,624.00 CAD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Innovotech changed from 89,409.00 CAD to 121,624.00 CAD, representing a 36.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Innovotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Innovotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Innovotech

All Key Metrics — Innovotech